For research use only. Not for therapeutic Use.
Streptokinase, β-hemolytic streptococcus (Lancefield Group C) is a bacteria-derived protein and a plasminogen activator. Streptokinase is widely used for the research of the blood-clotting disorders. Streptokinase improves reperfusion blood flow after coronary artery occlusion[1][2].
Sreptokinase (6000 IU/kg in 3 ml of saline; intracoronary; infused at 0.05 ml/min for 60 minutes beginning 30 minutes before reperfusion) maintains reperfusion coronary blood flow through a critical stenosis at a rate similar to baseline levels[2].
Catalog Number | I044245 |
CAS Number | 9002-01-1 |
Purity | ≥95% |
Reference | [1]. Vaughan DE, et al. Streptokinase-induced platelet aggregation. Prevalence and mechanism. Circulation. 1991;84(1):84-91. [2]. Mickelson JK, et al. Streptokinase improves reperfusion blood flow after coronary artery occlusion. Int J Cardiol. 1989;23(3):373-384. |